Author:
Edition: 2
Publisher: Academic Press
Binding: Hardcover
ISBN: 0123942969
Cancer Immunotherapy, Second Edition: Immune Suppression and Tumor Growth
There has been major growth in understanding immune suppression mechanisms and their relationships to cancer progression and therapy. Medical books Cancer Immunotherapy, Second Edition. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. The second edition of Cancer Immunotherapy highlights emerging principles of immune suppression that drive cancer and offers new ideas about how therapy can be improved by attacking these principles.
Beginning by reviewing current understanding of cancer immunobiology and therapeutics, the book moves into a deep examination of cancer immunosuppression and how it might be defeated. These chapters cover topics such as dendritic cells and co-inhibitory molecules, regulatory T-cells, tumor-associated macrophages, myeloid-derived suppressor cells, and factors in immune escape Medical books "Desk Reference of Clinical Pharmacology, Second Edition (CRC Desk Reference Series)". "Since the publication of the bestselling first edition of CRC Desk Reference of Clinical Pharmacology , dramatic discoveries in molecular medicine along with rapid technological advances have revolutionized the diagnosis and resulted in new medications to be used in the treatment of a broad range of human diseases. To stay abreast of these rapidly emerging drugs and novel avenues of treatment constant vigilance is required. Specifically prepared for healthcare professionals, Desk Reference of Clinical Pharmacology, Second Edition offers the most authoritative, comprehensive, informative, and useful book to include all drugs used in clinical practice. New to the Second Edition— · Novel therapies including the use of peptides in the treatment of peptic ulcers and IBS as well as new information on the use of melatonin in sleep disorders · Discoveries in molecular medicine, such as suicide gene therapy, monoclonal antibodies, and drug interference with signal transduction pathway therapeutics The book offers concise and informative AZ drug facts in an encyclopedia format and contains brief descriptions of conditions, diseases, and disorders presented along with their applicable treatments. The completely expanded introductory chapters contain short review entries on the pharmacokinetic basis of therapeutics, concepts of pharmacodynamics, and the principles of drug-drug interactions and drug-food interactions. They include discussions on state-of-the-art treatments such as immunotherapy of cancer, antisense therapies, suicide gene therapy, and pharmacogenomics, which is leading to tailor-made drugs based on genetic makeup. The second edition of the Desk Reference of Clinical Pharmacology contains more entries, up-to-date information on revolutionizing therapeutics, and an exhaustive list of maladies and their treatments. It is a definitive reference for any member of a healthcare delivery team and a valuable resource for those involved in the study of clinical pharmacology.File Size: 22140 KBPrint Length: 824 pagesPublisher: CRC Press; 2 edition (May 14, 2012) Sold by: Amazon Digital Services, Inc.Language: EnglishASIN: B008KZUL2Y"
Download link for "Desk Reference of Clinical Pharmacology, Second Edition (CRC Desk Reference Series)"
Medical Book Cancer Immunotherapy, Second Edition
Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. The second edition of Cancer Immunotherapy highlights emerging principles of immune suppression that drive cancer and offers new ideas about how therapy can be improved by attacking these principles.
Beginning by reviewing current understanding of cancer immunobiology and therapeutics, the book moves into a deep examination of cancer immunosuppression and how it might be defeated. These chapters cover topics such as dendritic cells and co-inhibitory molecules, regulatory T-cells, tumor-associated macrophages, myeloid-derived suppressor cells, and factors in immune escape.
Authored by two internationally recognized leaders in cancer biology and immunology, this book provides basic, translational, and clinical cancer researchers an indispensable overview of immune escape as a critical trait in cancer, and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.
- Synthesizes concepts that are useful to both cancer immunologists and pharmacologists
- Summarizes the latest insights into how immune escape defines an essential trait of cancer
- Includes numerous illustrations to clarify advanced concepts
